RLYB
Rallybio Corporation
NASDAQ · Healthcare · Biotechnology · US
$16.93
+0.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.13x
- PEG TTM
- —
- Price / book
- 0.95x
- Price / sales
- 139.13x
- Price / cash flow
- 3.41x
Enterprise value
- Enterprise value
- -$3.0M
- EV / sales
- -4.60x
- EV / EBITDA
- -0.11x
- EV / EBIT
- 0.13x
- Market cap
- $89.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026